Note: This is an open invitation, and may be forwarded to interested parties.
Narcolepsy is a chronic neurological disorder involving loss of the brain's ability to regulate sleep-wake cycles. In fall 2009, monovalent influenza A/H1N1/pdm09 vaccines were introduced globally as a response to the influenza A/H1N1 2009 pandemic. Cases of narcolepsy in children and adolescents following vaccination with the AS03-adjuvanted Pandemrix® vaccine were reported in August 2010 by Sweden and Finland. Since 2013, Ontario has been participating in an international study funded by the US Centers for Disease Control and Prevention to see if the AS03-adjuvanted Arepanrix® vaccine (also produced by GSK, but using a slightly different manufacturing process) was associated with narcolepsy. At this presentation, Dr. Kwong will discuss the preliminary Ontario results from this study.
DISCLAIMER: The opinions expressed by speakers and moderators do not necessarily reflect the official policies or views of Public Health Ontario, nor does the mention of trade names, commercial practices, or organizations imply endorsement by Public Health Ontario.
Presenter: Jeff Kwong
Jeff Kwong is a Senior Scientist at the Institute for Clinical Evaluative Sciences (ICES), a Scientist at Public Health Ontario, a Family Physician at the Toronto Western Family Health Team, and an Associate Professor in the Department of Family and Community Medicine and the Dalla Lana School of Public Health at the University of Toronto. Key research interests include infectious diseases epidemiology and health services research using linkable data, influenza vaccine and vaccination program evaluation, and assessing the health and economic burden of infectious diseases.
PHO Grand Rounds are also approved by Council of Professional Experience for professional development hours (PDHs) for members of the Canadian Institute of Public Health Inspectors (CIPHI). For more information, contact email@example.com.
Stay up-to-date on upcoming events and calls for abstracts by visiting our calendar.
If you have submissions, or questions or comments about the items above, send them to firstname.lastname@example.org.
Public Health Ontario is committed to complying with the Accessibility for Ontarians with Disabilities Act (AODA).
If you require accommodations to participate in this event, please contact 647-260-7100 or email@example.com.